Chemotherapy plus radiotherapy versus radiotherapy alone in patients with anaplastic glioma: a systematic review and meta-analysis Lei ZhangXiaojun WuYicheng Lu Review 10 February 2013 Pages: 719 - 726
Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies Nadège KindtJulie PreillonSven Saussez Original Paper 25 January 2013 Pages: 727 - 737
Vimentin as a poor prognostic factor for triple-negative breast cancer Nami YamashitaEriko TokunagaYoshihiko Maehara Original Paper 26 January 2013 Pages: 739 - 746
Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer Dina SchützeKarin Milde-LangoschVolkmar Müller Original Paper 29 January 2013 Pages: 747 - 754
Detection of circulating tumor cells in different stages of prostate cancer Mark ThalgottBrigitte RackMargitta Retz Original Paper 29 January 2013 Pages: 755 - 763
TNF-β +252 A>G polymorphism and susceptibility to cancer Lin YangRennan FengWenbo Wang Original Paper 03 February 2013 Pages: 765 - 772
Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection Xiaohong ChenBoheng ZhangJian Zhou Original Paper 03 February 2013 Pages: 773 - 781
Short-term versus long-term hormone therapy plus radiotherapy or prostatectomy for prostate cancer: a systematic review and meta-analysis Zhi-Rui ZhouXiao-Dong ZhuZhong-Guo Liang Original Paper 05 February 2013 Pages: 783 - 796
Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer Binglan ZhangXuelei MaYuquan Wei Original Paper 06 February 2013 Pages: 797 - 807
Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers Isabell WitzelMonika GraeserVolkmar Müller Original Paper 08 February 2013 Pages: 809 - 816
Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component Inkeun ParkYong Mee ChoHanjong Ahn Original Paper 09 February 2013 Pages: 817 - 827
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO) Umut DemirciGulnihal TufanMustafa Benekli Original Paper 12 February 2013 Pages: 829 - 835
Insulin-like growth factor 1 and musculoskeletal pain among breast cancer patients on aromatase inhibitor therapy and women without a history of cancer Lisa GallicchioRyan MacDonaldKathy J. Helzlsouer Original Paper 14 February 2013 Pages: 837 - 843
Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test Yusuke SuzukiKenji ImaiHisataka Moriwaki Original Paper 15 February 2013 Pages: 845 - 852
Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis T. GamucciA. VaccaroP. Vici Original Paper Open access 15 February 2013 Pages: 853 - 860
Simultaneous activation of T helper function can augment the potency of dendritic cell-based cancer immunotherapy Koji TeramotoYasuhiko OhshioKeiichi Kontani Original Paper 15 February 2013 Pages: 861 - 870
Laparoscopic radical prostatectomy plus extended lymph nodes dissection for cases with non-extra node metastatic prostate cancer: 5-year experience in a single Chinese institution Ming-Kun ChenYun LuoXin Gao Original Paper 16 February 2013 Pages: 871 - 878
Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer Kiyoshi MisawaTakeharu KanazawaHiroyuki Mineta Original Paper 19 February 2013 Pages: 879 - 889
PIK3CA mutation is associated with poor survival among patients with metastatic colorectal cancer following anti-EGFR monoclonal antibody therapy: a meta-analysis Shuangjie WuYu GanYifan Tang Original Paper 24 February 2013 Pages: 891 - 900